Porous Ti-10Mo alloys were fabricated by powder metallurgy using a space-holder method. The pore characteristics, microstructure, mechanical properties, in vitro biocompatibility, and in vivo osseointegration of the fabricated alloys were systematically investigated. The results show that with different weight ratios of the space-holder (NH 4 -HCO 3 ) added, all of the porous Ti-10Mo alloys sintered at 1,300°C exhibited a typical Widmanstätten microstructure. The porosity and average pore size of the porous structures can be controlled in the range of 50.8%-66.9% and 70.1-381.4 μm, respectively. The Ti-10Mo alloy with 63.4% porosity exhibited the most suitable mechanical properties for implant applications with an elastic modulus of 2.9 GPa and a compressive yield strength of 127.5 MPa. In vitro, the alloyconditioned medium showed no deleterious effect on the cell proliferation. The cell viability in this medium was higher than that of the reference group, suggesting non-toxicity and good biological characteristics of the alloy specimens. In vivo, after eight weeks' implantation, new bone tissue formed surrounding the alloy implants, and no noticeable inflammation was observed at the implantation site. The bone bonding strength of the porous Ti-10Mo alloy increased over time from 46.6 N at two weeks to 176.4 N at eight weeks. Suitable mechanical properties together with excellent biocompatibility in vitro and osteointegration in vivo make the porous Ti-10Mo fabricated by powder metallurgy an attractive orthopedic implant alloy.
INTRODUCTION
Titanium (Ti) and some of its alloys have been widely utilized in the medical field due to their high specific strength, excellent corrosion resistance, and biocompatibility in the human body environment [1] [2] [3] [4] [5] . However, current widely-used Ti alloys, such as extra-low interstitial (ELI) Ti-6Al-4V (wt.% hereafter), Ti-5Al-2.5Fe and Ti-6Al-7Nb, have the risk of releasing toxic aluminum (Al) and vanadium (V) ions in vivo, which can cause health-related problems, e.g., Alzheimer's disease and neuropathy [6] . Also, the elastic modulus of these alloys (~110 GPa) is much higher than that of cortical bone (3-30 GPa) [7] and trabecular or cancellous bone (0.02-3 GPa) [7] , which results in severe stress shielding, leading to premature implant failure. Therefore, much effort has been made to develop Al-free and V-free lowmodulus biocompatible β-Ti alloys. Notable examples include the United States Food and Drug Administration (FDA)-approved proprietary alloys Ti-13Nb-13Zr and Ti12Mo-6Zr-2Fe, and the non-proprietary alloy Ti-15Mo. In particular, binary Ti-Mo alloys containing 4%-20% molybdenum (Mo) have received significant attention due to their simplicity and reasonable cost [8] [9] [10] [11] [12] [13] [14] [15] , as well as their ability to cause only a very low amount of artifact as seen in magnetic resonance imaging (MRI) compared with other β-Ti alloys [16] .
As a commonly used β-phase stabilizing element in Ti, Mo is non-toxic below an ion concentration of 8.5 μg L β-phase, while increasing the strength and wear resistance [18] . Also, it can contribute to regulating the acid-base balance in the human body [19] [20] [21] . The near-β alloy Ti15Mo has been used in the clinic since 1998 [12] . Previous studies have proved that solid-solution hardening in Ti-Mo alloys appears to peak at 10%-12% Mo and that Ti-(10-12.5)Mo alloys (335-350 HV) are harder than Ti6Al-4V (294 HV) and Ti-13Nb-13Zr (285 HV) under the same conditions [8] . From an application-and-design point of view, a lower Mo content is always preferred. Minimizing the addition of Mo reduces the cost and the potential risk. Furthermore, reducing the amount of Mo also lowers the melting point of Ti-Mo alloys, which makes the alloys easy to process. Accordingly, the composition of Ti-10Mo was selected as a practical option in this study.
As mentioned above, a mismatch in elastic modulus between the implant and the bone will cause a stress shielding effect and may eventually lead to implant failure. Even though the elastic modulus of solid Ti-Mo alloys can be decreased to~65 GPa, this is still about two times greater than that of human bone (0.02-30 GPa). Hence, to further reduce the negative influence of this incompatibility and improve the biological fixation of implants to the surrounding tissues, a porous structure is introduced to the Ti-10Mo alloy [22] . The porous structure allows new bone tissue ingrowth and can achieve bonding between the implant and the bone tissue. Additionally, an open-cellular porous structure in implants also provides space for body fluid transportation [23] [24] [25] [26] [27] [28] , which facilitates new bone tissue generation, modeling and remodeling. Several previous studies have indicated that porous Ti-(7.5-15)Mo alloys can be processed by different techniques, such as selective laser sintering and powder metallurgy (PM) [29] [30] [31] [32] , and their salient characteristics, mainly their promising mechanical properties and corrosion resistance, make these alloys attractive candidates as an implant material. However, the in vivo osteointegration of porous Ti-Mo alloys is still rarely investigated in the literature so far, but it is crucial for their clinical use.
In this paper, porous Ti-10Mo alloys were fabricated by PM using a space-holder technique from hydride-dehydride (HDH) Ti powder and hydrogen-reduced Mo powder. The pore characteristics, microstructure, mechanical properties, in vitro biocompatibility, and in vivo osteointegration of these porous Ti-10Mo alloys were systematically assessed. This study aims to establish the necessary understanding of the low-cost porous Ti-10Mo alloys for orthopedic implant applications and to provide the basics supporting their practical clinical applications.
EXPERIMENTS AND METHODS

Materials preparation and characterization
The HDH Ti powder and the hydrogen-reduced Mo powder (Beijing Xing Rong Yuan Technology Co. Ltd, Beijing, China) of 500 mesh (<25 μm) with purity of 99.9% were used as the raw materials for the fabrication of the binary Ti-10Mo alloy. The chemical compositions of the metal powders are listed in Table 1 . The Ti-10Mo powder mixtures were blended with space-holder particles (ammonium hydrogen carbonate, NH 4 HCO 3 ) for 3 h, and then was cold-pressed into a cylindrical compact under 260 MPa. Finally, the isothermal sintering was carried out in the argon (Ar) protection environment at 1,300°C for 2 h. The detailed fabricating process is available in our previous study [33] .
An X-ray tomography scanning technique (nanoVoxel-2000, Sanying Precision Instruments Co. Ltd, Tianjin, China) was used to analyze the internal pore structure of the specimens. After scanning, the computed tomography (CT) datasets were used to produce a series of original reconstructed slice images using a back projection algorithm. Then the slice images were input into the Avizo software to be reconstructed. The total porosity, connected porosity and average pore sizes of the specimens were calculated by Avizo, as described in our previous study [33] . X-ray diffraction (XRD) for phase analysis was conducted with a Dmax-RB X-ray diffractometer (Cu Kα, λ=0.15406 nm, Rigaku, Tokyo, Japan). A scanning electron microscope (SEM) (JSM-6480LV JEOL, Tokyo, Japan) equipped with an energy dispersive X-ray detector (EDS) was used to analyze the microstructure. Before microstructure observation, the working surface of each sample was ground, polished, and etched using the Kroll's In vitro biocompatibility test Indirect and direct cytotoxicity tests were carried out with murine osteoblast cells (MC3T3-E1) to examine the in vitro biocompatibility of the fabricated porous Ti-10Mo alloy. For comparison, as-cast dense Ti-6Al-4V and CPTi were studied simultaneously, which are commonly used in clinical practice. The cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS), 100 U mL −1 penicillin, and 100 μg mL −1 streptomycin at 37°C in a humidified atmosphere of air containing 5% CO 2 . The specimens were cut into discs of 10 mm in diameter and 1 mm in thickness, and the surfaces were polished with SiC papers up to 5,000 grit. Then the specimens were ultrasonically cleaned and sterilized for further cytotoxicity assessment. In the indirect testing, the specimens were placed individually in a 24-well tissue culture plate and immersed in DMEM at a ratio of 3 cm 2 mL −1 (the surface area of the disc to the volume of media) for 24 h to obtain extracts. Then, the cells were incubated by the extracts and DMEM (reference group) in 96-well plates at a density of 5,000 cells per 100 mL. At specific times (one day, two days, and three days), 10 μL of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution was added to each well and was incubated for 4 h. Then 100 μL of dimethyl sulfoxide (DMSO) was added to each well, and further incubated for 5 min. The absorbance was recorded by a multimode detector on a Synergy HT (BioTek, US) at a wavelength of 570 nm. The cell viability ratio (CVR) was calculated by the formula given by: CVR = (OD 570 nm in experimental extract/OD 570 nm in control extract) × 100%. Based on the International Standard ISO 10993-5 [34] , the cytotoxic level was categorized into six groups: 0: ≥100%; 1: 75%-99%; 2: 50%-74%; 3: 25%-49%; 4: 1%-24%; 5: ≤1%. The CVR values were analyzed using oneway ANOVA (P < 0.05), and the results were expressed as the mean ± standard deviation (SD). P < 0.05 was considered statistically significant. Five specimens were tested, and the average values were obtained.
In the direct testing, MC3T3-E1 cells, at an initial density of 1 × 10 5 cells/well, were seeded on the sterilized porous Ti-10Mo, as-cast dense Ti-6Al-4V and CP-Ti alloys in 24-well plates. The adhesion analysis of the MC3T3-E1 cells cultured with the specimens for 1 and 4 h was conducted to estimate the living status in the early stage. After 1, 2, and 3 days of culture, the cell cytoskeleton and nuclei were stained by phalloidin and DAPI (Sigma-Aldrich), respectively, and the morphology of the cells on the surface of each specimen was observed by a fluorescence microscope. For SEM observation, the culture medium was removed first and the cells were rinsed with phosphate buffered saline three times. Immediately after the last wash, a fixing solution (4% glutaraldehyde) was added to the culture wells and they were kept at room temperature for 30 min. Once the cells were fixed, a dehydration process took place by sequential washings in 60%, 70%, 80%, 90%, 95% and 100% ethanol solutions for 10 min at each step. After that the specimens were gold-coated and observed by SEM.
Mo ion release
To examine Mo ion release, Ti-Mo specimens were immersed in DMEM containing 10% FBS, 100 U mL −1 penicillin, and 100 μg mL −1 streptomycin at 37°C in a humidified atmosphere of air containing 5% CO 2 for 1, 2, 3, 5, and 7 days at a ratio of 3 cm 2 mL −1 (the surface area of the disc to the volume of media). The Mo ion concentration in the solution was analyzed by an inductively coupled plasma spectrometry (PerkinElmer, Optima 5300 DV).
Animal experiment
Adult male Sprague-Dawley (SD) rats of 200-250 g in weight from Academy of Military Medical Sciences were kept at 25°C with free access to food and water for three days before surgery. All surgical procedures were done under a strict aseptic protocol. The rats were anesthetized by an intraperitoneal injection of 1% (wt.%) pentobarbital (Merck, Germany) solution, 10-12.5 mL kg
. The knee joint region was scrubbed with a tincture of iodine and 75% ethanol and shaved subsequently. Then the animal was given a local anesthetics of 0.5% (wt.%) lidocaine solution by infiltration anesthesia to the periosteum. A hand drill with a screw rod of 1.3 mm diameter and 10 mm length was used to drill a hole through the cortical bone, trabeculae and bone marrow located at the distal femur. Individual porous Ti-10Mo rods were pressed into the pre-drilled holes in the right femurs. The diameter and length of the implanted specimens were 1.3 ± 0.05 mm and 3 ± 0.05 mm. The specimen was always implanted into the left limbs. The animals were received an intramuscular injection of clavulanate-potentiated amoxicillin in the first three days and were inspected daily for clinical signs of complications or adverse reactions. The rats were allowed unrestricted cage activity postoperatively. No attempt was made to limit their activity after surgery. The animal experiment was performed at the Beijing Institute of Nanoenergy and Nanosystems, in accordance with the animal ethics approval and guidance of the Animal Research Committee of the Institute.
After survival periods of two, four, and eight weeks, the rats were euthanized. Six rats were sacrificed at every time point, and the distal pieces of each femur, spanning 5 mm in length and containing the Ti-10Mo alloy rod, were obtained. Then the six specimens were observed by micro-CT (Quantum GX, PerkinElmer). After that, three specimens were used for histological analysis, and the other three specimens were utilized for biomechanical analysis.
For a hard-tissue slicing experiment, the specimens were dehydrated in a graded ethanol series (70% to 100%) after fixation in 10% formalin solution for two weeks. They were then embedded without decalcification in a methylmethacrylate (MMA) solution, which polymerized at 37°C within one week. Then, the specimens were sliced into 250 μm slices using a low-speed diamond saw (Leica Microtome, Wetzlar, Germany). After that, the specimens were polished to a final thickness of about 20 μm and glued to glass slides with permanent mounting medium (Fisher Scientific, USA). Finally, the specimens were stained with toluidine blue and were observed by optical microscopy and laser confocal fluorescence microscopy (Leica TCS SP8, Leica, Germany). In the laser confocal fluorescence microscopy observation, the specimens (metals) were reflected by the laser and marked as cyan. The implant sites were evaluated macroscopically in a semiquantitative manner concerning inflammation, hemorrhage, and necrosis.
For biomechanical testing, a specifically designed device was used to perform push-out testing of the porous Ti-10Mo alloy. The harvested bone block containing each test specimen was fixed onto the holder with resin, and the testing machine (Instron) was loaded parallel to the long axis of the test specimen at a cross-head speed of 0.5 mm min −1 . The peak load was recorded as the bonding strength between the bone and the test specimen. Three specimens were tested, and the average bonding strengths were obtained.
RESULTS AND DISCUSSION
Microstructure, pore characteristics, and mechanical properties Fig. 1 shows XRD patterns and microstructures of the Ti10Mo alloys with different ratios of space-holder added. It can be seen from Fig. 1a that there were no significant differences in the XRD patterns of the fabricated porous Ti-10Mo alloys with different weight ratios of spaceholder added. The diffraction peaks of the porous Ti10Mo suggested that the alloys mainly consisted of α and β phase. During the furnace cooling, α phase precipitated from the β phase intracrystallinely and along the grain boundaries, leading to the formation of the Widmanstätten structure (α+β). Also, there were no diffraction peaks of elemental Mo in the as-sintered Ti-10Mo alloys. Fig. 1b-d shows the microstructures of the porous Ti10Mo alloys with different weight ratios of space-holder added. It can be seen that all the specimens exhibited uniform typical Widmanstätten structures, which is consistent with the XRD analysis. Also, as Fig. 1e-g shown, no segregation of the element Mo was discovered, indicating that Mo had completely diffused into the Ti matrix after sintering at 1,300°C for 2 h. The pore characteristics of the porous Ti-10Mo extracted from X-ray tomography scanning, including total porosity (P t ), connected porosity (P c ), and average pore size, are summarized in Table 2 . It can be seen that, with an increase in the amount of space-holder from 35% to 55%, the total porosity, connected porosity, and average pore size all increased significantly. The average pore size of the porous Ti-10Mo alloy ranged from 70 to 380 μm.
The mechanical properties of the Ti-10Mo alloys with different porosities were evaluated by compression testing. The engineering stress-strain curves and the mechanical properties of the porous Ti-10Mo alloys are shown in Fig. 2 . It can be seen that the porous Ti-10Mo alloys with different porosities exhibited similar stressstrain behavior. No fractures were observed during the compression process, demonstrating the excellent elasticplastic deformation capability of the porous Ti-10Mo alloys. Compression tests were stopped at 50% strain for all the porous specimens. The compressive yield strength decreased from 248.2 to 69.9 MPa as the porosity increased from 50.5% to 66.9% (Fig. 2b) . The elastic modulus of the porous Ti-10Mo alloys ranged from 1.7 GPa for the Ti-10Mo with a porosity of 66.9% to 6.4 GPa for the Ti-10Mo with a porosity of 50.5%.
The pore characteristics and mechanical properties are two critical factors to affect the osteogenic ability of the implant materials. It has been demonstrated that the porous structure can provide space for new bone tissue ingrowth and pathways for body fluid and nutrient transportation, thereby accelerating osseointegration of the implant, promoting bone regeneration and growth [35] [36] [37] . It is generally accepted that pores with sizes between 100 and 400 μm are optimal for bone ingrowth [38, 39] . With an addition of 40% space holder, the porous Ti-10Mo exhibited 54.7% total porosity, 50.5% connected porosity and an average pore size of 140.9 µm. Hence, the porous Ti-10Mo alloys with 54.7%-66.9% porosity are suitable for implant material applications regarding the average pore size. Additionally, with the suitable average pore size, the large porosity is favorable for bone osteointegration. However, the rise of porosity inevitably deteriorates the strength of the materials. Generally, the compressive yield strength of human trabecular or cancellous bone is about 2-80 MPa and the elastic modulus of ranges from 0.02 to 3.0 GPa [7] . Results from this study indicate that the compressive yield strength of the porous Ti-10Mo alloy with 63.4% porosity conforms to the basic compressive mechanical property requirement of human trabecular bone and the corresponding elastic modulus is also close to that of human cancellous bone. Hence, the satisfied mechanical properties together with the suitable average pore size and larger porosity confirms that the porous Ti-10Mo alloy with 63.4% porosity can be anticipated as a promising implant material candidate. Therefore, the next section analyzes the in vitro biocompatibility and in vivo osteointegration of the Ti-10Mo alloy with 63.4% porosity. Fig. 3 shows the MTT cytotoxicity results of the porous Ti-10Mo alloy extracts for 1, 2, 3, and 7 days compared with those of the CP Ti and Ti-6Al-4V alloy extracts (commonly used in clinical practice), as well as the control (cultured by DMEM directly). The data are expressed as the CVR, and the control group has a CVR of 100%, which is accepted as a reference in determining the CVR of specimens [40, 41] . As shown in Fig. 3 , the average CVR of all the experimental specimens is above 99%. According to ISO 10993-5 [34] , the cytotoxicity grade of these Ti alloys for MC3T3-E1 cells is 0-1. The porous Ti10Mo alloy exhibited a slightly higher average CVR value than the CP Ti and Ti-6Al-4V, but there were no statistically significant differences among them (P > 0.05). The nuclear staining was used to evaluate the number of the adhered cells on materials' surface at early stage. Fig. 4 shows the adhered MC3T3-E1 cells on the surfaces of porous Ti-10Mo, Ti-6Al-4V, and CP-Ti at 1 and 4 h. It can be seen that very few MC3T3-E1 cells adhered on the surfaces of each alloy in the early period of 1 h. With the incubation time extended to 4 h, there were more cells with well adhesions. Compared with Ti-6Al-4V and CPTi, there are more cells adhered on the surface of the porous Ti-10Mo alloys, but there were no statistically significant differences among them (P > 0.05). This result demonstrates that all of these alloys have good cytocompatibility. The more adhered MC3T3-E1 cells on the porous Ti-10Mo alloy in the earlier stage also provide the opportunity for further observation of cell proliferation.
In vitro biocompatibility evaluation
The cell proliferation on the surface of the porous Ti10Mo, dense CP Ti and Ti-6Al-4V alloys after culturing for different periods (1, 2, and 3 days) was observed by fluorescence microscopy (Fig. 5) . It can be seen that there was no significant difference of the cytoskeleton structure (green) observed among the three groups, which implied that cells could grow normally on the porous Ti-10Mo alloy as well as on that of CP-Ti and Ti-6Al-4V. Additionally, it can be seen that there were only a few nuclei on the surface of the porous Ti-10Mo alloy (Fig. 5a ) after one day culture. With prolongation of culture time, the number of nuclei increased significantly ( Fig. 5d and g ). After three days culture, there are more cells on the surface of the porous Ti-10Mo alloys than that on the surface of CP-Ti and Ti-6Al-4V, which indicated that the porous structure might even promote cell growth. These results demonstrate that the porous Ti-10Mo alloy had no cytotoxic effect on MC3T3-E1 cells, which is consistent with the MTT results.
The cell morphology of MC3T3-E1 cells grown in the interior of the porous Ti-10Mo alloy after culturing for specific periods of 1, 2, 3 and 4 days and the cumulative Mo ion concentration in DMEM for 1, 2, 3, 5 and 7 days are described in the Figs S1 and S2 (Supplementary information), respectively. The results showed that with the prolongation of culture time, the cells were connected together and filled the pores gradually. The amount of released Mo ions increased slightly at the first five days, but it was barely increasing afterwards.
The in vitro cytotoxicity of an implant material is dependent not only on the toxicity of its alloying elements but also its corrosion resistance. In the present study, Ti10Mo has lower Mo content than Ti-15Mo alloy (used clinically since 1998), which means the ions release from Ti-10Mo alloy may be less when implanted into the human body. That makes Ti-10Mo alloy have higher safety than Ti-15Mo alloy in the practical clinic application. Additionally, it has been demonstrated that the corrosion resistance of Ti-Mo alloys is superior to those of CP-Ti and Ti-6Al-4V due to the spontaneously formed stable TiO 2 -MoO 3 passive film on its surface [42] [43] [44] [45] [46] . This spontaneously formed oxide film can provide a bio-inert layer in the aggressive body fluids, effectively inhibiting the release of metal ions. This is also why the amount of releasing Mo ions is very small after seven days immersion. Furthermore, physical factors also play an essential role in determining the interaction between implant materials and surrounding tissues. Previous studies have demonstrated that the presence of pores facilitates the attachment of osteoblast-like cells [7, 46] . In this study, the porous Ti-10Mo alloy exhibited a larger average pore size than those reported [7] , which is expected to provide a large surface area for cells to interact on through providing more mechanical anchoring sites, therefore facilitating the growth of cells. As a result, the porous Ti10Mo alloy showed high cell viability during the MTT assay and excellent biocompatibility with MC3T3-E1 cells.
In vivo osteointegration evaluation
All animals recovered uneventfully after surgery and reached their allocated time point with no postoperative morbidity noted. Fig. 6 shows the appearance of the implant position and implants surface condition after the operation. It can be seen from Fig. 6a -e that no infections occurred on the implant site, and with prolongation of implantation time, new hair grew gradually. Also, no macroscopic signs of intolerance were observed for any of the implants in term of inflammation, hemorrhage, and necrosis (Fig. 6f , an example after two weeks implantation).
Micro-CT analysis was performed on the porous Ti10Mo alloys after 2, 4 and 8 weeks' implantation to discover the presence of any possible defects or gaps, and the bonding around the implant (Fig. 7) . It can be seen that there was a gap between the bone and implant after implantation for 2 weeks (Fig. 7a) . As time increased, this gap decreased gradually and disappeared after 8 weeks (Fig. 7c) . To obtain more information about the bone ingrowth onto the porous Ti-10Mo alloy, high-resolution images of the new bone formed on the surface of the implant were taken, as shown in Fig. 7d-f . It can be seen that new bone started to grow on the implant surface after implantation for 2 weeks. With an increase in the implantation time, the amount of new bone increased significantly, and the implant was surrounded by new bone after 8 weeks of implantation (Fig. 7f) . Histological evaluation at the bone-implant interface was performed to evaluate the osteointegration after implantation for 2, 4, and 8 weeks. Fig. 8 shows the histological section images of the porous Ti-10Mo specimens at different weeks of implantation. Signs of osteoid-like new bone formation were observed after 2 weeks (Fig. 8a  and d) . The blue regions surrounding the implant area represent the newly formed osteoid, indicating noncytotoxicity of the implant. However, only a small amount of new bone formed surrounding the implant, with a gap between the implant and new bone (Fig. 8a , which is consistent with the micro-CT results. With an increase in the implantation time, the amount of newly formed bone gradually increased, as shown in Fig. 8b and c. The newly formed bone almost surrounded the implant with only a few visible gaps after 8 weeks of implantation (Fig. 8c) . Similar results were obtained inside the porous structure by fluorescence microscopy, as shown in Fig. 8d and e. After 2 weeks' implantation, newly formed bone started to grow in the pores (Fig. 8a) . With an increase in the implantation time to 4 weeks, the newly formed bone inside the pores increased (Fig. 8e) . The pores of the scaffolds were almost filled with newly formed bone after 8 weeks of implantation (Fig. 8f) , indicating excellent in vivo osteointegration.
Further analysis of the bone-tissue integration was carried out using push-out testing, and the load-displacement curves are shown in Fig. 9 . The bonding strength between the porous Ti-10Mo alloy and bone increased over time from 46.6 N after 2 weeks to 176.4 N after 8 weeks. In addition, the bonding strength after 16 weeks of implantation was measured as 193.3 N. It can be seen that the bonding strength between implant and bone only increased slightly from 176.4 N after 8 weeks' implantation to 193.3 N after 16 week's implantations, which means that the new bone regeneration was almost complete after 8 weeks of implantation. Compared with dense Ti-6Al-4V [47] , the time of new bone regeneration for the porous Ti-10Mo alloy is much faster (24 weeks for dense Ti-6Al-4V and 8 weeks for porous Ti-10Mo alloy), indicating that the porous Ti-10Mo alloy has better osteogenic ability. This is mainly because porous metal materials have the ability to provide biological anchorage for surrounding bone tissues and greater contact area at the implant-bone interface.
The excellent in vivo osteointegration of the porous Ti10Mo alloy in this study likely resulted from both the lower elastic modulus and the open-cell porous structure. It is believed that a low elastic modulus benefits new bone formation in cancellous bone [48] . In the present study, the elastic modulus of the porous Ti-10Mo alloy with 63.4% porosity was about 2.9 GPa, which is significantly lower than that of solid Ti-alloy reported in the literature, such as 65 GPa for solid Ti-7.5Mo [48] ,~70 GPa for solid Ti-13Nb-13Zr [49] , and~110 GPa for solid Ti-6Al-4V and CP-Ti. The lower elastic modulus of the porous Ti10Mo alloy promoted new bone formation. This is consistent with the results reported by Lin et al. [48] , who demonstrated that the new bone formation surrounding the solid Ti-7.5Mo (65 GPa) increased over time, while the new bone formation surrounding solid Ti-6Al-4V (110 GPa) decreased over time. Moreover, as mentioned above, a high open pore volume allows more body fluids to be transported through the interconnected pores, which subsequently accelerates the healing process by allowing tissue to grow inside the implants and improves the biological fixation [50] . A similar influence of porosity on bone ingrowth has also been reported in porous bioactive Ti implants [51, 52] . Hence, it can be concluded that the porous Ti-10Mo scaffolds fabricated by a simple powder metallurgical method exhibited low elastic modulus, high compressive yield strength, and excellent in vitro biocompatibility and in vivo osteointegration, and so can be anticipated as an attractive orthopedic implant alloy.
CONCLUSIONS
Porous Ti-10Mo alloys with porosities ranging from 50% to~67% and average pores size from 70 to 381 μm were fabricated successfully. The fabricated Ti-10Mo alloys showed a typical Widmanstäten microstructure, and achieved wide properties with elastic modulus of 6.4-1.7 GPa and compression yield strength of 248.2-76.9 MPa. The porous Ti-10Mo alloys displayed no adverse effects on cell behavior, and the cytotoxicity level was ranked 0-1 grade. In addition, the porous Ti-10Mo alloys exhibited excellent biocompatibility and osteointegration, and the bonding strength between the porous Ti-10Mo alloy and bone increased over time from 46.6 N after 2 weeks to 176.4 N after 8 weeks and 193.3 N after 16 weeks of implantation. This porous Ti-10Mo alloy fabricated by powder metallurgy can be considered an attractive orthopedic implant material by virtue of its excellent mechanical properties, in vitro biocompatibility, and in vivo osteointegration.
